The Medical University of Vienna is a public university located in Vienna, Austria. It is the direct successor to the faculty of medicine at the University of Vienna, founded in 1365 by Rudolf IV, Duke of Austria.

During the past decade, Medical University of Vienna conducted 468 clinical trials. In the 10-year time frame, 468 clinical trials started and 110 clinical trials were completed, i.e. on average, 23.5% percent of trials that started reached the finish line to date. In the past 5 years, 174 clinical trials started and 60 clinical trials were completed. i.e. 34.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medical University of Vienna" #1 sponsor was "Medical University of Vienna" with 339 trials, followed by "Celgene" with 29 trials sponsored, "Boehringer Ingelheim" with 16 trials sponsored, "Hoffmann-La Roche" with 13 trials sponsored and "Baxalta now part of Shire" with 13 trials sponsored. Other sponsors include 405 different institutions and companies that sponsored additional 268 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medical University of Vienna" #1 collaborator was "Medical University of Vienna" with 31 trials as a collaborator, "Charite University, Berlin, Germany" with 7 trials as a collaborator, "Hoffmann-La Roche" with 7 trials as a collaborator, "Karolinska Institutet" with 7 trials as a collaborator and "Takeda Development Center Americas, Inc." with 7 trials as a collaborator. Other collaborators include 721 different institutions and companies that were collaborators in the rest 557 trials.

According to Clinical.Site data, the most researched conditions in "Medical University of Vienna" are "Ulcerative Colitis" (14 trials), "Crohn Disease" (12 trials), "Multiple Myeloma" (12 trials), "Heart Failure" (11 trials) and "Coronary Artery Disease" (10 trials). Many other conditions were trialed in "Medical University of Vienna" in a lesser frequency.

Most popular intervention types in "Medical University of Vienna" are "Drug" (380 trials), "Other" (128 trials), "Device" (119 trials), "Procedure" (78 trials) and "Diagnostic Test" (46 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (106 trials), "Gemcitabine" (12 trials), "Dexamethasone" (9 trials), "Rituximab" (8 trials) and "Prednisone" (7 trials). Other intervention names were less common.

The vast majority of trials in "Medical University of Vienna" are 717 trials for "All" genders, 63 trials for "Female" genders and 39 trials for "Male" genders.

Currently, there are NaN active trials in "Medical University of Vienna". 5 are not yet recruiting, 158 are recruiting, 77 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 409 completed trials in Medical University of Vienna, 8 suspended trials, and 55 terminated clinical trials to date.

Out of the total trials that were conducted in Medical University of Vienna, 45 "Phase 1" clinical trials were conducted, 123 "Phase 2" clinical trials and 211 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 53 trials, and there were also 184 trials that are defined as “Not Applicable".

Medical University of Vienna has several departments that took part in Clinical trials: "Medical University of Vienna, Department of Ophthalmology" - 25 trials, "Department of Psychiatry and Psychotherapy, Medical University of Vienna" - 22 trials, "Medical University Of Vienna, Department of Internal Medicine III" - 20 trials, "Department of Anaesthesia, Medical University of Vienna" - 18 trials, "Medical University of Vienna,Department of Obstetrics and Gynecology" - 17 trials, "Department of Clinical Pharmacology, Medical University Vienna" - 16 trials, "Universitätsklinik für Innere Medizin III" - 11 trials, "Dept of Internal Medicine" - 10 trials, "Medical University of Vienna, Department of Neurology" - 10 trials, "Medical University Vienna, Dptm. of Obstetrics & Gynaecology" - 8 trials, "Department of Dermatology, Medical University of Vienna" - 8 trials, "Universitatsklinikum fur Innere Medizin II" - 8 trials, "Medical University of Vienna, Department of Surgery" - 7 trials, "Department of Internal Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, Austria" - 6 trials, "Department of Neurosurgery, Medical University of Vienna" - 6 trials, "Medizinische Universität Wien; Univ.Klinik für Dermatologie" - 6 trials, "Department of Clinical Pharmacology, Medical University of Vienna" - 159 trials, "Medizinische Universität Wien; Univ.Klinik für Innere Medizin I - Abt. für Onkologie" - 33 trials, "Allgemeines Krankenhaus - Universitätskliniken Klinische Abteilung für Onkologie" - 5 trials, "Medical University of Vienna Internalmedicine 1, Hematology" - 5 trials, "Medical University of Vienna, Department of Traumatology" - 5 trials, "Medical University of Vienna - Department of Surgery, Division of Cardiac Surgery" - 5 trials, "Department of Cardiology, Medical University of Vienna" - 5 trials, "Medizinische Universität Wien; Univ.Klinik für Innere Medizin III - Gastroenterologie & Hepatologie" - 4 trials, "Medizinische Universität Wien; Univ.Klinik für Innere Medizin I - Hämatologie & Hämostaseologie" - 4 trials